Tue, October 19, 2021
Mon, October 18, 2021
Sun, October 17, 2021
Fri, October 15, 2021
Thu, October 14, 2021
Wed, October 13, 2021
Tue, October 12, 2021
Mon, October 11, 2021
Sun, October 10, 2021
Fri, October 8, 2021

Jeffrey Hung Downgraded (ACAD) to Hold and Held Target at $20 on, Oct 14th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-20-on-oct-14th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jeffrey Hung of Morgan Stanley, Downgraded "ACADIA Pharmaceuticals Inc." (ACAD) to Hold and Held Target at $20 on, Oct 14th, 2021.

Jeffrey has made no other calls on ACAD in the last 4 months.



There are 3 other peers that have a rating on ACAD. Out of the 3 peers that are also analyzing ACAD, 1 agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tazeen Ahmad of "B of A Securities" Maintained at Hold with Decreased Target to $25 on, Thursday, August 5th, 2021


These are the ratings of the 2 analyists that currently disagree with Jeffrey


  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $26 on, Thursday, August 5th, 2021
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $28 on, Thursday, August 5th, 2021

Publication Contributing Sources